Walgreen (WAG) Tops Q2 Views Amid Light Flu Season; PSC Takes Off in Sign-Ups
Tweet
Share
E-mail
Get Alerts WAG Hot Sheet
Price: $76.05 --0%
Financial Fact:
Average shares outstanding assuming dilution: 956M
Today's EPS Names:
MAYS, CRMT, REPL, More
Financial Fact:
Average shares outstanding assuming dilution: 956M
Today's EPS Names:
MAYS, CRMT, REPL, More
Join SI Premium – FREE
Walgreen (NYSE: WAG) shares are looking healthy Tuesday morning following the company's second-quarter 2012 results which showed a beat on the top and bottom lines amid a tough cold/flu season.
Revenue for the retail pharma giant moved 0.8 percent from $18.50 billion in the same period last year to $18.65 billion. Comps were down 1.5 percent, surprising when Walgreen reported front-end comps rose 2.1 percent, traffic was up 0.7 percent in comparable stores, and basket size jumped 1.4 percent.
Net earnings fell 7.6 percent to $683 million, or 78 cents per diluted share.
The Street expected revs of $18.53 billion and EPS of 77 cents.
Flu shots totaled 5.5 million, versus 6.2 million in the same period last year.
Comparable-store prescription sales dipped 3.9 percent, while overall prescription sales dropped 1.7 percent.
Walgreen said it had 700,000 new Prescription Savings Club sign-ups in January alone, following the exit of its partnership with Express Scripts (Nasdaq: ESRX).
***And, yes, we inquired: there is no special handshake or secret decoder ring given to you after signing-up to be part of the PSC.
Shares are up 2 percent Tuesday.
Revenue for the retail pharma giant moved 0.8 percent from $18.50 billion in the same period last year to $18.65 billion. Comps were down 1.5 percent, surprising when Walgreen reported front-end comps rose 2.1 percent, traffic was up 0.7 percent in comparable stores, and basket size jumped 1.4 percent.
Net earnings fell 7.6 percent to $683 million, or 78 cents per diluted share.
The Street expected revs of $18.53 billion and EPS of 77 cents.
Flu shots totaled 5.5 million, versus 6.2 million in the same period last year.
Comparable-store prescription sales dipped 3.9 percent, while overall prescription sales dropped 1.7 percent.
Walgreen said it had 700,000 new Prescription Savings Club sign-ups in January alone, following the exit of its partnership with Express Scripts (Nasdaq: ESRX).
***And, yes, we inquired: there is no special handshake or secret decoder ring given to you after signing-up to be part of the PSC.
Shares are up 2 percent Tuesday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Citrini flags overheating concerns as leverage, chip rally weigh on KOSPI
- Carnival Corp. (CCL) Tops Q2 EPS by 8c, Beats on Revenue; Offers Guidance
- Carnival shares drop despite earnings beat on weak guidance
Create E-mail Alert Related Categories
Corporate News, EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
